Glybera

Type: Product
Name: Glybera
First reported Aug 11 2014 - Updated Aug 12 2014 - 2 reports

uniQure Expands Gene Therapy Stable with InoCard Acquisition

uniQure , which boasts the first and only gene therapy product to receive regulatory approval in the EU, Glybera , has acquired InoCard, an early-stage biotechnology company focused on the development of gene therapy products for cardiac disease. The ... [Published Genetic Engineering News - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

uniQure Acquires Cardiology Gene Therapy Company InoCard

--Combination of uniQure Leadership and Fundamental InoCard Discovery May Enable Transformative Gene Therapy Treatment of Congestive Heart Failure--Amsterdam, the Netherlands, and Heidelberg, Germany, August 11, 2014 - uniQure N.V. (NASDAQ: QURE), a leader ... [Published Noodls - Aug 11 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Advanced therapy medicinal products

This article summarises what advanced therapy medicinal products (ATMPs) are, how their regulation is performed and the associated challenges, and discusses some of ATMPs registered in Europe and their therapeutic usesTiene Bauters PharmD PhDClinical ... [Published Hospital Pharmacy Europe - Aug 08 2014]
Entities: Cartilage, ATMP, Lipoprotein
First reported Aug 04 2014 - Updated Aug 04 2014 - 1 reports

Chiesi and uniQure delay Glybera launch to add data

Netherlands-based venture capital backed human gene therapy firm uniQure and privately-held Italian drugmaker Chiesi Farmaceutici have provided an update on preparations relating to the launch of Glybera (alipogene tiparvovec).Expanding on the original ... [Published Pharma Letter - Aug 04 2014]
First reported Jun 18 2014 - Updated Jun 19 2014 - 2 reports

uniQure, Medison sign distribution agreement for Glybera

uniQure, a Netherlands-based provider of human gene therapy, has an exclusive distribution agreement with Medison Pharma, an Israeli healthcare marketing group. ... [Published PBR - News - Jun 19 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

[tt] [GRG] NewAbs: Genome Editing to Cure AIDS

To Members and Friends of the Los Angeles Gerontology Research Group:         Genome editing to cure disease... -- Steve Coles " Can Genome Editing Cure AIDS? " by Hank Greely, Center for Law and Biosciences at Stanford Law School and by ... [Published TranshumanTech - Mar 27 2014]
Entities: Genome, HIV/AIDS, Mutation
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Gene Expression Analysis Market (Gene Profiling, Bioinformatics, Data Analysis Software) worth $4.3 Billion by 2018 - New Report by MarketsandMarkets

This report broadly categorizes the global gene expression analysis market into three segments, namely, instrumentation, consumables, and services. According to the new market research report, “Gene Expression Analysis Market by Technology (DNA Microarray, ... [Published PRWeb - Mar 27 2014]

Quotes

...uniQure, with its unique and scalable manufacturing process, is in the best position to push this program forward," Aldag told FierceBiotech. "InoCard's founders wanted to partner with us because of the proven expertise we have in gene therapy."
...and accelerate their development by the application of our proven modular platform," commented Jörn Aldag, uniQure's Chief Executive Officer. "There is strong scientific rationale that addressing calcium dysregulation leads to an astounding effect in congestive heart failure. We are very excited to have Patrick Most and Hugo Katus join us. Their groundbreaking re and expertise in heart failure is a great contribution to uniQure, and we believe that together we will deliver the best-in-class treatment for congestive heart failure."
"We are fully supportive of Chiesi's approach to include additional data demonstrating multiyear benefit for a one time treatment in our pricing and reimbursement documentation. Adding long-term data will significantly strengthen the quality of the application" said Jorn Aldag, chief executive of uniQure
"Glybera represents an exciting opportunity for Medison to continue its leadership in offering new innovative treatments in Israel"

More Content

All (18) | News (9) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
uniQure Expands Gene Therapy Stable with InoCar... [Published Genetic Engineering News - Aug 12 2014]
UniQure bets on a gene therapy for heart failure [Published FierceBiotech - Aug 11 2014]
uniQure Acquires Cardiology Gene Therapy Compan... [Published Noodls - Aug 11 2014]
Advanced therapy medicinal products [Published Hospital Pharmacy Europe - Aug 08 2014]
Chiesi and uniQure delay Glybera launch to add ... [Published Pharma Letter - Aug 04 2014]
Chiesi and uniQure Provide Update on Glybera(r)... [Published GlobeNewswire: Acquisitions News - Aug 04 2014]
Between the beginning of last year and early Ap... [Published Live-PR.com - Jul 31 2014]
uniQure, Medison sign distribution agreement fo... [Published PBR - News - Jun 19 2014]
uniQure and Medison Sign Glybera Distribution A... [Published PR Newswire - Jun 18 2014]
uniQure Announces Analysis of Six-Year Follow-u... [Published GlobeNewswire: Acquisitions News - Jun 03 2014]
uniQure and Medison Sign Glybera(R) Distributio... [Published GlobeNewswire: Acquisitions News - May 29 2014]
[tt] [GRG] NewAbs: Genome Editing to Cure AIDS [Published TranshumanTech - Mar 27 2014]
Gene Expression Analysis Market (Gene Profiling... [Published PRWeb - Mar 27 2014]
uniQure and Chiesi Announce Six Year Follow-up ... [Published GlobeNewswire: Acquisitions News - Mar 17 2014]
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
These Days, You Can't Spell Financings Of The F... [Published The IN VIVO Blog - Feb 07 2014]
Dutch gene therapy pioneer raises $82 mln in U.... [Published PE Hub Blog - Feb 06 2014]
Europe: Early Communications with Regulators is... [Published Pharmaceutical Executive - Jan 16 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
uniQure, Medison sign distribution agreement fo... [Published PBR - News - Jun 19 2014]
uniQure, a Netherlands-based provider of human gene therapy, has an exclusive distribution agreement with Medison Pharma, an Israeli healthcare marketing group. ...
[tt] [GRG] NewAbs: Genome Editing to Cure AIDS [Published TranshumanTech - Mar 27 2014]
To Members and Friends of the Los Angeles Gerontology Research Group:         Genome editing to cure disease... -- Steve Coles " Can Genome Editing Cure AIDS? " by Hank Greely, Center for Law and Biosciences at Stanford Law School and by ...
Forbion Capital-backed uniQure completes IPO [Published PE Hub Blog - Feb 13 2014]
Forbion Capital Partners -backed uniQure , which develops gene therapy products, has completed an initial public offering at a price of $17 per share on the NASDAQ . Jefferies and Leerink Partners acted as joint book-running managers and Piper ...
These Days, You Can't Spell Financings Of The F... [Published The IN VIVO Blog - Feb 07 2014]
It turns out a lot of the words that contain the letters "IPO" are biomedical words: Pluripotent. Liposomal. Adiposis. Gallipot . And it turns out a lot of biomedical companies have IPO in them, too. Since we last met 14 days ago , dear reader, ...
Dutch gene therapy pioneer raises $82 mln in U.... [Published PE Hub Blog - Feb 06 2014]
(Reuters) – A small Dutch company behind the Western world’s first approved gene therapy priced its shares above the expected range in a U.S. stock offering on Wednesday, showing the current investor appetite for biotechnology. Amsterdam-based uniQure ...
1

Press Releases

sort by: Date | Relevance
Chiesi and uniQure Provide Update on Glybera(r)... [Published GlobeNewswire: Acquisitions News - Aug 04 2014]
uniQure Announces Analysis of Six-Year Follow-u... [Published GlobeNewswire: Acquisitions News - Jun 03 2014]
uniQure and Medison Sign Glybera(R) Distributio... [Published GlobeNewswire: Acquisitions News - May 29 2014]
uniQure and Chiesi Announce Six Year Follow-up ... [Published GlobeNewswire: Acquisitions News - Mar 17 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.